Literature DB >> 2422898

Heterogeneity of calcium channels in mast cells and basophils and the possible relevance to pathophysiology of lung diseases: a review.

N Chand, J L Perhach, W Diamantis, R D Sofia.   

Abstract

Calcium plays a critical role in the formation and secretion of a wide variety of chemical mediators. Calcium slow-channel blockers, e.g. nifedipine and verapamil, have been shown to inhibit the synthesis of SRS (SRS-A, leukotrienes) in human and guinea pig lung tissue, thromboxane A2 formation in rat lung and platelet activating factor in human neutrophils. Verapamil and nifedipine also prevent the release of lysosomal enzymes from rabbit and human polymorphonuclear neutrophils. Calcium-channel blockers produce variable inhibitory effects on allergic and nonallergic histamine secretion. Ca++-entry blockers also inhibit the Ca++ uptake (influx) into mast cells. Many of these inhibitory effects of Ca++ antagonists are antagonized by an increased extracellular Ca++ ion concentration. The magnitude of the inhibitory influences of Ca++-channel blockers on allergic and nonallergic release of chemical mediators appears to depend on the cell source, species, nature and the concentration of the secretory stimuli as well as on the composition and pH of buffers and the concentration of Ca++-entry blockers used. The data summarized in this review suggest the existence of a functional heterogeneity of Ca++ channels in leukocytes, mast cells and basophils. Interference with the Ca++-dependent steps involved in the formation and/or release of chemical mediators appears to be the primary mode of action for Ca++-channel blockers in these cells. The differential effects of Ca++ antagonists on Ca++-dependent activation of phospholipase A2,5-lipoxygenase, and calmodulin (or other intracellular Ca++-binding proteins) in different cell types (mast cells, basophils, leukocytes, lung tissue, etc.) may explain the variation of their effectiveness in inhibiting the synthesis/release of chemical mediators and antagonizing bronchoconstriction in response to diverse stimuli. During the process of hypersensitization and in immediate hypersensitivity diseases, Ca++ homeostasis (uptake, mobilization, distribution, relocation, etc.) may be altered in leukocytes (mast cells, basophils) and lung tissues. The altered Ca++ homeostasis could be responsible for the induction of airway hyperreactivity in asthmatics and for hyperreleasability of chemical mediators from leukocytes, mast cells and other cell types.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422898     DOI: 10.1007/bf01965507

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  62 in total

1.  Effect of verapamil in obstructive airways disease.

Authors:  T Ringqvist
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

2.  Effects of nifedipine on antigen-induced bronchoconstriction.

Authors:  A F Henderson; R W Heaton; L S Dunlop; J F Costello
Journal:  Am Rev Respir Dis       Date:  1983-05

3.  Stimulation and inhibition of histamine release from isolated rat mast cells. Dual effects of the ionophore A23187.

Authors:  B Diamant; S A Patkar
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

4.  Effect of calcium antagonists on allergen-induced asthma.

Authors:  S Y So; W K Lam; D Y Yu
Journal:  Clin Allergy       Date:  1982-11

5.  Effects of intravenous and aerosol nifedipine on prostaglandin F2 alpha and histamine-induced bronchoconstriction in anesthetized dogs.

Authors:  P E Malo; M A Wasserman; R L Griffin
Journal:  J Pharmacol Exp Ther       Date:  1982-05       Impact factor: 4.030

6.  Inhibition of allergic histamine release by azelastine and selected antiallergic drugs from rabbit leukocytes.

Authors:  N Chand; J Pillar; W Diamantis; R D Sofia
Journal:  Int Arch Allergy Appl Immunol       Date:  1985

7.  Nifedipine--a calcium channel blocker--in asthmatic patients. Interaction with terbutaline.

Authors:  K Svedmyr; C G Löfdahl; N Svedmyr
Journal:  Allergy       Date:  1984-01       Impact factor: 13.146

8.  Calcium antagonists and histamine secretion from rat peritoneal mast cells.

Authors:  M Ennis; P W Ind; F L Pearce; C T Dollery
Journal:  Agents Actions       Date:  1983-04

9.  A calcium antagonist, nifedipine, modifies exercise-induced asthma.

Authors:  P J Barnes; N M Wilson; M J Brown
Journal:  Thorax       Date:  1981-10       Impact factor: 9.139

10.  Interference of the calcium antagonists verapamil and nifedipine with lysosomal enzyme release from rabbit polymorphonuclear leukocytes.

Authors:  J G Elferink
Journal:  Arzneimittelforschung       Date:  1982
View more
  4 in total

1.  RWJ-22108--a novel airway tissue--selective calcium channel blocker.

Authors:  J B Moore; W C Miller; S Mockoviak
Journal:  Agents Actions       Date:  1993-09

2.  Divalent cation dependence of the inhibition by phenothiazines of mediator release from mast cells.

Authors:  P T Peachell; F L Pearce
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

Review 3.  Calcium homeostasis and the activation of calcium channels in cells of the immune system.

Authors:  S Grinstein; A Klip
Journal:  Bull N Y Acad Med       Date:  1989-01

4.  The obligatory role of calcium in the development of antigen-induced airway hyperreactivity to cold provocation in the rat isolated trachea.

Authors:  N Chand; W Diamantis; R D Sofia
Journal:  Br J Pharmacol       Date:  1987-05       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.